Diamonds and Dogs


AstraZeneca (AZN) beat estimates without much help from their Covid-19 vaccine. AstraZeneca is up 4% to a three-month high following strong earnings as sales rose 15% to $7.32 billion thanks in part to their cancer drugs and their cardiovascular and rhythm management treatments.

No more need for cleaning supplies. Clorox (CLX) is down 4% following disappointing earnings and guidance. Clorox noted that health-and-wellness sales decreased 8% in the quarter, mainly due to lower shipments of cleaning and disinfecting products in both the retail and professional channels. Clorox is down 25% since peaking last August.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.